End-of-day quote
Lima
03:30:00 17/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.55
PEN
|
0.00%
|
|
0.00%
|
0.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
184.5
|
180.4
|
140.8
|
79.37
|
92.68
|
74.58
|
Enterprise Value (EV)
1 |
418.8
|
417.6
|
369.7
|
297.1
|
309.7
|
321
|
P/E ratio
|
5.44
x
|
-57.9
x
|
34.4
x
|
3.26
x
|
1.26
x
|
-
|
Yield
|
7.23%
|
-
|
-
|
-
|
32.4%
|
-
|
Capitalization / Revenue
|
0.5
x
|
0.54
x
|
0.47
x
|
0.23
x
|
0.18
x
|
0.17
x
|
EV / Revenue
|
1.13
x
|
1.25
x
|
1.25
x
|
0.88
x
|
0.6
x
|
0.75
x
|
EV / EBITDA
|
4.24
x
|
8.58
x
|
6.55
x
|
3.78
x
|
1.9
x
|
3.51
x
|
EV / FCF
|
9.41
x
|
62.2
x
|
29.4
x
|
37.9
x
|
5.66
x
|
47.6
x
|
FCF Yield
|
10.6%
|
1.61%
|
3.4%
|
2.64%
|
17.7%
|
2.1%
|
Price to Book
|
0.5
x
|
0.49
x
|
0.29
x
|
0.17
x
|
0.24
x
|
-
|
Nbr of stocks (in thousands)
|
5,03,201
|
5,03,201
|
5,03,201
|
5,03,201
|
5,03,201
|
5,03,201
|
Reference price
2 |
0.3667
|
0.3534
|
0.2084
|
0.1255
|
0.1842
|
0.1482
|
Announcement Date
|
30/04/19
|
16/06/20
|
30/04/21
|
29/04/22
|
27/03/23
|
25/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
370.4
|
335.2
|
296.5
|
337.8
|
520.1
|
429.1
|
EBITDA
1 |
98.84
|
48.66
|
56.48
|
78.53
|
163
|
91.56
|
EBIT
1 |
70.74
|
18.08
|
25.56
|
48.7
|
132.5
|
60.34
|
Operating Margin
|
19.1%
|
5.39%
|
8.62%
|
14.42%
|
25.49%
|
14.06%
|
Earnings before Tax (EBT)
1 |
53.2
|
0.612
|
15.21
|
38.64
|
114.9
|
44.04
|
Net income
1 |
33.89
|
-3.073
|
3.044
|
19.37
|
73.31
|
27.73
|
Net margin
|
9.15%
|
-0.92%
|
1.03%
|
5.73%
|
14.1%
|
6.46%
|
EPS
2 |
0.0674
|
-0.006106
|
0.006049
|
0.0385
|
0.1457
|
-
|
Free Cash Flow
1 |
44.49
|
6.711
|
12.57
|
7.837
|
54.71
|
6.747
|
FCF margin
|
12.01%
|
2%
|
4.24%
|
2.32%
|
10.52%
|
1.57%
|
FCF Conversion (EBITDA)
|
45.01%
|
13.79%
|
22.26%
|
9.98%
|
33.56%
|
7.37%
|
FCF Conversion (Net income)
|
131.27%
|
-
|
413.09%
|
40.47%
|
74.62%
|
24.33%
|
Dividend per Share
2 |
0.0265
|
-
|
-
|
-
|
0.0596
|
-
|
Announcement Date
|
30/04/19
|
16/06/20
|
30/04/21
|
29/04/22
|
27/03/23
|
25/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
234
|
237
|
229
|
218
|
217
|
246
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.371
x
|
4.874
x
|
4.053
x
|
2.772
x
|
1.331
x
|
2.692
x
|
Free Cash Flow
1 |
44.5
|
6.71
|
12.6
|
7.84
|
54.7
|
6.75
|
ROE (net income / shareholders' equity)
|
9.9%
|
-1.07%
|
1.63%
|
5.85%
|
19.9%
|
7.65%
|
ROA (Net income/ Total Assets)
|
5.6%
|
1.43%
|
2%
|
3.71%
|
9.64%
|
4.28%
|
Assets
1 |
605.3
|
-215.6
|
152.5
|
522.6
|
760.2
|
647.1
|
Book Value Per Share
2 |
0.7400
|
0.7200
|
0.7100
|
0.7400
|
0.7800
|
-
|
Cash Flow per Share
2 |
0.0300
|
0.0300
|
0.1100
|
0.0900
|
0.1000
|
-
|
Capex
1 |
23.5
|
33.2
|
22.8
|
25.6
|
42.8
|
41.1
|
Capex / Sales
|
6.34%
|
9.92%
|
7.67%
|
7.58%
|
8.23%
|
9.58%
|
Announcement Date
|
30/04/19
|
16/06/20
|
30/04/21
|
29/04/22
|
27/03/23
|
25/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +5.41% | 106B | | -3.11% | 64.74B | | +73.33% | 49.34B | | +17.24% | 39.15B | | +6.13% | 32.86B | | +12.77% | 20.29B | | +15.03% | 17.21B | | +19.06% | 15.28B | | +6.28% | 14.58B |
Other Commodity Chemicals
|